Cornelius S. Sobel
Plus aucun poste en cours
Profil
Dr. Cornelius S.
Sobel is Head-European Development & Regulatory Affairs at Dragonfly Sciences, Inc.
Dr. Sobel was previously employed as Chief Scientific Officer by Biopartners GmbH and Head-Production & Regulatory Affairs by Merck KGaA.
He received his undergraduate degree from The Johannes Gutenberg University of Mainz.
Anciens postes connus de Cornelius S. Sobel
| Sociétés | Poste | Fin |
|---|---|---|
Dragonfly Sciences, Inc.
 Dragonfly Sciences, Inc. BiotechnologyHealth Technology Dragonfly Sciences, Inc. develops biosimilar products of monoclonal antibodies and soluble receptors. The company was founded by Frank D. Lee in 2005 and is headquartered in Wellesley, MA. | Conseiller Juridique Général | - |
| MERCK KGAA | Conseiller Juridique Général | - |
Biopartners GmbH
 Biopartners GmbH Pharmaceuticals: MajorHealth Technology Biopartners GmbH engages in the development of biopharmaceutical products in the fields of endocrinology, multiple sclerosis, and virology. The company was founded in 2000 and is headquartered in Baar, Switzerland. | Fondateur | - |
Formation de Cornelius S. Sobel
| The Johannes Gutenberg University of Mainz | Undergraduate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MERCK KGAA | Health Technology |
| Entreprise privées | 2 |
|---|---|
Biopartners GmbH
Biopartners GmbH Pharmaceuticals: MajorHealth Technology Biopartners GmbH engages in the development of biopharmaceutical products in the fields of endocrinology, multiple sclerosis, and virology. The company was founded in 2000 and is headquartered in Baar, Switzerland. | Health Technology |
Dragonfly Sciences, Inc.
Dragonfly Sciences, Inc. BiotechnologyHealth Technology Dragonfly Sciences, Inc. develops biosimilar products of monoclonal antibodies and soluble receptors. The company was founded by Frank D. Lee in 2005 and is headquartered in Wellesley, MA. | Health Technology |
